Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPRICS: EPO to protect renal function after cardiac surgery
2011-001673-70Phase 2Completed
- Sponsor
- Skåne University Hospital
- Start
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of epoetin alfa in acute kidney failure (AKF) (2 arms), sponsored by Skåne University Hospital. Primary endpoint: Change in plasma cystatin C. Started Jun 2011; status: completed.
02
Drugs
epoetin alfa
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on 2011-001673-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001673-70.